Allosteric nucleic acid catalysts

Current Opinion in Structural Biology

Volumn 10, Issue 3, 2000, Pages 318-325

  Soukup, Garrett A ^a   Breaker, Ronald R ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RIBOZYME; RNA;

ALLOSTERISM; CATALYST; GENETIC ENGINEERING; PRIORITY JOURNAL; REVIEW;

EID: 0034126964     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(00)00090-7     Document Type: Review

References (45)

1. •].
2. •].
3. •].
4. •], serves as an excellent resource for current information regarding the diversity of nucleic acid catalysts from a structural and mechanistic perspective.
5. Celander D.W., Cech T.R. Visualizing the higher order folding of a catalytic RNA molecule. Science. 251:1991;401-407.
6. Zarrinkar P.P., Williamson J.R. The kinetic folding pathway of the Tetrahymena ribozyme reveals possible similarities between RNA and protein folding. Nat Struct Biol. 3:1996;432-438.
7. Treiber D.K., Williamson J.R. Exposing the kinetic traps in RNA folding. Curr Opin Struct Biol. 9:1999;339-345. A thoughtful examination of the kinetic complexities of RNA folding. Although the folding of nucleic acid catalysts largely conforms to a hierarchical model, whereby secondary structure formation precedes and largely dictates tertiary interactions, each aspect of RNA folding can be significantly impacted by inherent conformational heterogeneity or metal ion dependence.
8. Soukup G.A., Breaker R.R. Nucleic acid molecular switches. Trends Biotechnol. 17:1999;469-476.
9. Soukup G.A., Breaker R.R. Allosteric ribozymes. Gaur R.K., Krupp G. Ribozymes: Biology and Biotechnology. 2000;Eaton Publishing, Natick, MA. in press.
10. Forster A.C., Symons R.H. Self-cleavage of plus and minus RNAs of a virusoid and a structural model for the active sites. Cell. 49:1987;211-220.
11. Haseloff J.P., Gerlach W.L. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature. 334:1988;585-591.
12. Sassanfar M., Szostak J.W. An RNA motif that binds ATP. Nature. 364:1993;550-553.
13. Tang J., Breaker R.R. Rational design of allosteric ribozymes. Chem Biol. 4:1997;453-459.
14. Tang J., Breaker R.R. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection. RNA. 3:1997;914-925.
15. Jiang F., Kumar R.A., Jones R.A., Patel D.J. Structural basis of RNA folding and recognition in an AMP-RNA aptamer complex. Nature. 382:1996;183-186.
16. Patel D.J., Suri A.K., Jiang F., Jiang L., Fan P., Kumar R.A., Nonin S. Structure, recognition and adaptive binding in RNA aptamer complexes. J Mol Biol. 272:1997;645-664.
17. Hermann T., Patel D.J. Adaptive recognition by nucleic acid aptamers. Science. 287:2000;820-825. A comprehensive review of RNA-ligand interactions. The molecular interactions that dictate discriminatory ligand recognition by RNA aptamers are examined in detail.
18. Tang J., Breaker R.R. Mechanism for allosteric inhibition of an ATP-sensitive ribozyme. Nucleic Acids Res. 26:1998;4222-4229. A detailed analysis of the ATP-inhibited hammerhead ribozyme reveals a mechanism of allosteric regulation that involves steric interactions between the aptamer and ribozyme domains. This study demonstrates how biophysical and biochemical data can together yield a clear mechanistic understanding of allosteric ribozyme function.
19. •].
20. •] similarly employ modular rational design techniques [13] to generate allosteric ribozymes that are responsive to FMN.
21. Fedor M.J., Uhlenbeck O.C. Kinetics of intermolecular cleavage by hammerhead ribozymes. Biochemistry. 31:1992;12 042-12 054.
22. Ruffner D.E., Stormo G.D., Uhlenbeck O.C. Sequence requirements of the hammerhead RNA self-cleavage reaction. Biochemistry. 29:1990;10 695-10 702.
23. Burgstaller P., Famulok M. Isolation of RNA aptamers for biological cofactors by in vitro selection. Angew Chem Int Ed Engl. 33:1995;1084-1087.
24. Fan P., Suri A.K., Fiala R., Live D., Patel D.J. Molecular recognition in the FMN-RNA aptamer complex. J Mol Biol. 258:1996;480-500.
25. Jenison R.D., Gill S.C., Pardi A., Polisky B. High resolution molecular discrimination by RNA. Science. 263:1994;1425-1429.
26. Zimmermann G.R., Jenison R.D., Wick C.L., Simorre J.P., Pardi A. Interlocking structural motifs mediate molecular discrimination by a theophylline-binding RNA. Nat Struct Biol. 4:1997;644-649.
27. Porta H., Lizardi P.M. An allosteric hammerhead ribozyme. Biotechnology. 13:1995;161-164.
28. Kuwabara T., Warashina M., Tanabe T., Tani K., Asano S., Taira K. A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo. Mol Cell. 2:1998;617-627. This study demonstrates the utility of allosteric ribozymes as controllable therapeutic agents for modulating gene expression in vivo. Although the effector and substrate mRNA for this oligonucleotide-dependent allosteric hammerhead ribozyme construct is endogenous to the target cells, allosteric ribozymes that respond to exogenous effector molecules (i.e. pharmaceutical agents) may function similarly to control mRNA stability.
29. Robertson M.P., Ellington A.D. In vitro selection of an allosteric ribozyme that transduces analytes to amplicons. Nat Biotechnol. 17:1999;62-66. An oligonucleotide-dependent allosteric RNA ligase ribozyme identified from an in vitro selection experiment is used to demonstrate how allosteric catalysts can be used to detect low concentrations of effector molecules. Effector concentration can be determined directly from the catalytic activity of the ribozyme or by selective amplification of the resulting ribozyme ligation product.
30. Breaker R.R., Joyce G.F. Inventing and improving ribozyme function: rational design versus iterative selection methods. Trends Biotechnol. 12:1994;268-275.
31. Williams K.P., Bartel D.P. In vitro selection of catalytic RNA. Nucleic Acids Mol Biol. 10:1996;367-381.
32. Osborne S.E., Ellington A.D. Nucleic acid selection and the challenge of combinatorial chemistry. Chem Rev. 97:1997;349-370.
33. Soukup G.A., Breaker R.R. Engineering precision RNA molecular switches. Proc Natl Acad Sci USA. 96:1999;3584-3589. The intersection of modular rational design and combinatorial selection techniques was used to isolate novel allosteric catalysts that contain unique sequence elements or 'communication modules' that function between an aptamer domain and the hammerhead ribozyme. Furthermore, certain communication modules exhibit the ability to control ribozyme activity in response to effector binding, regardless of the sequence or ligand specificity of the appended aptamer domain.
34. ••] for catalysts that are activated by compounds related to the cognate ligand. The identification of related aptamer-ligand interactions provides an opportunity to examine the details of molecular recognition and discrimination in RNA-ligand complexes, as well as novel effector-dependent catalysts.
35. Koizumi M., Soukup G.A., Kerr J.N.Q., Breaker R.R. Allosteric selection of ribozymes that respond to the second messengers cGMP and camp. Nat Struct Biol. 6:1999;1062-1071. The potential to generate allosteric ribozymes that respond to virtually any effector compound or signal is demonstrated. By attaching a random sequence region to the hammerhead ribozyme, allosteric catalysts that are activated by any one of a number of effector compounds can be developed simultaneously through allosteric selection, whereby novel ligand-binding domains are derived from the random sequence region.
36. Van Duyne G.D., Standaert R.F., Karplus P.A., Schreiber S.L., Clardy J. Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science. 252:1991;839-852.
37. Katz B.A. Binding to protein targets of peptidic leads discovered by phage display: crystal structures of streptavidin-bound linear and cyclic peptide ligands containing the HPQ sequence. Biochemistry. 34:1995;15 421-15 429.
38. Giebel L.B., Cass R., Milligan D.L., Young D., Arze R., Johnson C. Screening of cyclic peptide phage libraries identifies ligands that bind streptavidin with high affinities. Biochemistry. 34:1995;15 430-15 435.
39. 12)-binding aptamer does not encapsulate ligand as an integral component of the RNA fold. Rather, the RNA structure provides a complementary binding surface for the ligand. The structural pre-organization of this aptamer RNA probably contributes to its relatively high affinity for cyanocobalamin in comparison to other small molecule-aptamer interactions.
40. Li Y., Breaker R.R. Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2′-hydroxyl group. J Am Chem Soc. 121:1999;5364-5372.
41. Gold L., Polinsky B., Uhlenbeck O.C., Yarus M. Diversity of oligonucleotide functions. Annu Rev Biochem. 64:1995;763-797.
42. Chow C.S., Bogdan F.M. A structural basis for RNA-ligand interactions. Chem Rev. 97:1997;1489-1513.
43. Famulok M. Oligonucleotide aptamers that recognize small molecules. Curr Opin Struct Biol. 9:1999;324-329. A current and comprehensive review of small molecule-aptamer interactions. The aptitude of RNA to achieve high affinity for and specific molecular recognition of a variety of target ligands is apparent.
44. Marshall K.A., Ellington A.D. Training ribozymes to switch. Nat Struct Biol. 6:1999;992-994. The prospect of utilizing allosteric ribozymes in microchip arrays to concurrently assess the presence or concentration of difference metabolites or effector compounds is described in brief.
45. Robertson M.P., Ellington M.D. Design and optimization of effector-activated ribozyme ligases. Nucleic Acids Res. 28:2000;1751-1759.